Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Buller

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Texas Medicine|September 1, 1975
Tumoricidal steroids: potential cure for advanced breast and prostatic cancerR E Buller
Gynecologic Oncology|February 24, 2000
BRCA1: what do we know? What do we think we know? What do we really need to know?R E Buller
Clinical Obstetrics and Gynecology|November 26, 1999
Estrogen replacement therapy in endometrial and breast cancer survivorsV Mahavni, R E Buller
Obstetrics and Gynecology|August 12, 1998
Drug resistance in ovarian cancer: from the laboratory to the clinicA K Sood, R E Buller
The Western Journal of Medicine|April 1, 1990
An Ovarian Cancer Tumor Marker, CA 125, Comes of AgeR E Buller, P J Disaia
American Journal of Obstetrics and Gynecology|March 1, 1982
Pregnancy following cervical conizationR E Buller, H W Jones
Biochemical Pharmacology|January 1, 1976
The biology and mechanism of steroid hormone receptor interaction with the eukaryotic nucleusR E Buller, B W O'Malley
The Journal of Investigative Dermatology|January 1, 1977
Herman Beerman lecture. Mechanisms of steroid hormone actionB W O'Malley, R E Buller
Methods in Molecular Medicine|February 23, 2011
SSCP and Sequence Analysis of p53 Mutations in Ovarian TumorsA K Sood, R E Buller
Minerva Ginecologica|June 14, 2002
The role of p53 mutation in BRCA1-associated ovarian cancerS L Rose, R E Buller
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Texas Medicine|September 1, 1975
Tumoricidal steroids: potential cure for advanced breast and prostatic cancerR E Buller
Gynecologic Oncology|February 24, 2000
BRCA1: what do we know? What do we think we know? What do we really need to know?R E Buller
Clinical Obstetrics and Gynecology|November 26, 1999
Estrogen replacement therapy in endometrial and breast cancer survivorsV Mahavni, R E Buller
Obstetrics and Gynecology|August 12, 1998
Drug resistance in ovarian cancer: from the laboratory to the clinicA K Sood, R E Buller
The Western Journal of Medicine|April 1, 1990
An Ovarian Cancer Tumor Marker, CA 125, Comes of AgeR E Buller, P J Disaia
American Journal of Obstetrics and Gynecology|March 1, 1982
Pregnancy following cervical conizationR E Buller, H W Jones
Biochemical Pharmacology|January 1, 1976
The biology and mechanism of steroid hormone receptor interaction with the eukaryotic nucleusR E Buller, B W O'Malley
The Journal of Investigative Dermatology|January 1, 1977
Herman Beerman lecture. Mechanisms of steroid hormone actionB W O'Malley, R E Buller
Methods in Molecular Medicine|February 23, 2011
SSCP and Sequence Analysis of p53 Mutations in Ovarian TumorsA K Sood, R E Buller
Minerva Ginecologica|June 14, 2002
The role of p53 mutation in BRCA1-associated ovarian cancerS L Rose, R E Buller
Pageof 10